ACI Worldwide Redefines Payments with ACI Connetic
27.5.2025 07:00:00 CEST | Business Wire | Press Release
ACI Worldwide (NASDAQ:ACIW), an original innovator in global payments technology, has announced the integration of the major UK, EU and global networks’ payment capabilities into ACI Connetic, ACI’s transformative, cloud-native payments hub. These include Swift cross-border payments, RTGS payments including Target2, SEPA Instant RT1 and TIPS payments, with the addition of more capabilities planned.
For the first time in the industry, ACI Connetic brings together account-to-account (A2A), card payments and AI-driven fraud prevention on a unified cloud-native platform – making it simpler, faster and more cost-effective for banks and financial institutions (FI) to modernize their payments infrastructures.
Datos Insights recently called on banks to centralize payments and move forward with urgency to remain competitive in an increasingly complex payments world. The Datos report emphasizes the benefits of centralizing payment processing, arguing that it enables banks to streamline payment operations, reduce complexity, enhance efficiency and ultimately drive business growth.
Designed to meet the demands of modern banking, ACI Connetic enables FIs of all sizes to consolidate siloed systems and embrace a centralized approach to processing all payment types. It offers FIs unequalled scalability and resilience while minimizing risk and enabling them to deliver new services to customers much faster.
“ACI Connetic is not just a new product, it is a new standard for how banks must operate in the digital economy and approach payments transformation,” said Thomas Warsop, President and CEO of ACI Worldwide. “Against the backdrop of increasing payments complexity, the rise of new technologies and a shifting regulatory environment, ACI Connetic empowers financial institutions to unlock new revenue opportunities and navigate compliance in order to drive growth and financial inclusion.”
ACI Connetic is fast gaining traction with financial institutions in Europe and the United States. The platform’s cloud-native architecture, modular design and open APIs simplify integration with existing systems, speeding up deployment and time to value. Designed for financial institutions of any size, it is particularly suited for banks looking to modernize quickly and cost-effectively without sacrificing enterprise-grade capabilities.
ACI is collaborating with the world’s leading clearing and settlement systems—including the Bank of England, Pay.UK, ECB, EBA Clearing, and Stet, as well as Swift, the Federal Reserve and The Clearing House—to integrate their payments capabilities to offer banks across the globe the most prolific payment methods as part of ACI Connetic.
“We built ACI Connetic to give banks a future-proof foundation to meet the ever-increasing demand for faster, smarter and secure payments,” said Scotty Perkins, head of product for banking and intermediaries at ACI Worldwide. “Built for scalability, intelligence and resilience, ACI Connetic empowers banks to reduce complexity, accelerate product innovation and deliver new solutions to their customers in an unprecedented way and at unprecedented speed.”
ACI will be showcasing Connetic at EBAday 2025, Europe’s annual summit for the leading payments and transaction banking executives.
About ACI Worldwide
ACI Worldwide, an original innovator in global payments technology, delivers transformative software solutions that power intelligent payments orchestration in real time so banks, billers, and merchants can drive growth, while continuously modernizing their payment infrastructures, simply and securely. With 50 years of trusted payments expertise, we combine our global footprint with a local presence to offer enhanced payment experiences to stay ahead of constantly changing payment challenges and opportunities.
© Copyright ACI Worldwide, Inc. 2025
ACI, ACI Worldwide, ACI Payments, Inc., ACI Pay, Speedpay, and all ACI product/solution names are trademarks or registered trademarks of ACI Worldwide, Inc., or one of its subsidiaries, in the United States, other countries, or both. Other parties’ trademarks referenced are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250526652963/en/
Contacts
Media Contacts
Nick Karoglou | Head of Communications and Corporate Affairs |
nick.karoglou@aciworldwide.com
Katrin Boettger | Communications and Corporate Affairs Director |
katrin.boettger@aciworldwide.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom